Theophylline (anhydrous recalls

The FDA has published 1 recall involving Theophylline (anhydrous since 2020. The latest was reported on 1 Apr 2020. Most were for labeling errors. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2020

Last 12 months0reported

Class I00% of total

Ongoing0latest 1 Apr 2020

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why theophylline (anhydrous is recalled

Labeling Errors1100%

Companies

Nostrum Laboratories1100%

By year

20201100%

All theophylline (anhydrous recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
1 Apr 2020Drug	CLASS II	Theophylline (Anhydrous) Extended-Release Tablets, 400 mg recalled	Nostrum Laboratories	Labeling Errors	MO, TN

Should you stop taking Theophylline (anhydrous?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.